Bavarian Nordic News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.04.24	Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S (GlobeNewswire)
02.04.24	Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S. (GlobeNewswire)
21.03.24	Bavarian Nordic A/S – Notice Convening Annual General Meeting (GlobeNewswire)
13.03.24	Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland (GlobeNewswire)
12.03.24	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
06.03.24	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
06.03.24	Bavarian Nordic Publishes Annual Report 2023 (GlobeNewswire)
23.02.24	Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency (GlobeNewswire)
21.02.24	Bavarian Nordic delivered record financial results in 2023 (GlobeNewswire)
13.12.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
13.12.23	New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic (GlobeNewswire)
30.11.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
30.11.23	Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise (GlobeNewswire)
22.11.23	Bavarian Nordic to hold Capital Markets Days in February 2024 (GlobeNewswire)
16.11.23	Bavarian Nordic Announces Interim Results for the First Nine Months of 2023 (GlobeNewswire)
15.11.23	Ausblick: Bavarian Nordic zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
01.11.23	Erste Schätzungen: Bavarian Nordic gewährt Anlegern Blick in die Bücher (finanzen.net)
25.10.23	Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk (GlobeNewswire)
18.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
15.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
14.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
13.09.23	Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve (GlobeNewswire)
13.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
12.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
11.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
08.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
07.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
06.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
05.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
04.09.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
04.09.23	ÜBERBLICK/Anstehende Indexänderungen zum 18. September (Dow Jones)
01.09.23	INDEXÄNDERUNG/Vonovia verlassen Euro-Stoxx-50 - Munich Re kommen in Stoxx-50 (Dow Jones)
01.09.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
31.08.23	Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program (GlobeNewswire)
23.08.23	MÄRKTE EUROPA/Drohende Rezession lässt Marktzinsen fallen (Dow Jones)
23.08.23	Bavarian Nordic Announces First Half 2023 Results (GlobeNewswire)
06.08.23	Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents (GlobeNewswire)
03.08.23	Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. Government (GlobeNewswire)
22.07.23	Bavarian Nordic Provides Update on RSV Vaccine Program (GlobeNewswire)
27.06.23	Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate (GlobeNewswire)
23.06.23	Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve (GlobeNewswire)
20.06.23	Bavarian Nordic Reports Data from a Phase 3 Clinical Trial of its VLP-Based Chikungunya Virus Vaccine in Adults =65 Years of Age (GlobeNewswire)
16.06.23	Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate (GlobeNewswire)
12.06.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
23.05.23	Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such (GlobeNewswire)
23.05.23	Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise (GlobeNewswire)
17.05.23	Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program (GlobeNewswire)
15.05.23	Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions (GlobeNewswire)
09.05.23	Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations (GlobeNewswire)
09.05.23	Bavarian Nordic Announces Interim Results for the First Three Months of 2023 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

22.08.24		Bavarian Nordic-Aktie im Rally-Modus: Bavarian Nordic übertrifft Erwartungen um Längen
22.08.24		Ausblick: Bavarian Nordic legt Quartalsergebnis vor
20.08.24		Bavarian Nordic-Aktie dreht ins Minus: Produktion von Mpox-Impfstoff wird gesteigert - Halbjahreszahlen stehen an
23.08.22		Ausblick: Bavarian Nordic gewährt Anlegern Blick in die Bücher

22.08.24

Bavarian Nordic-Aktie im Rally-Modus: Bavarian Nordic übertrifft Erwartungen um Längen

22.08.24

Ausblick: Bavarian Nordic legt Quartalsergebnis vor

20.08.24

Bavarian Nordic-Aktie dreht ins Minus: Produktion von Mpox-Impfstoff wird gesteigert - Halbjahreszahlen stehen an

23.08.22

Ausblick: Bavarian Nordic gewährt Anlegern Blick in die Bücher

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Bavarian Nordic A/S

Aktien Top/Flop

Bavarian Nordic Peer Group Nachrichten

Meistgelesene Nachrichten